JHVEPhoto
- AMD (NASDAQ:AMD) was in focus on Monday as Melius Research upgraded the Dr. Lisa Su-led company, citing its potential in inferencing.
- Shares rose 0.5% in premarket trading.
- “Investors are about to envision even bigger GPU figures in 2026-2028 given a sustainable surge in inferencing, where investing in AMD’s platform seems to be more attractive for hyperscalers and Sovereigns,” Melius analyst Benjamin Reitzes wrote in a note to clients. “If we are right, the stock has a lot more to go.”
- Reitzes raised his rating to Buy from Hold and upped his price target to $175 from $110.
- In addition, Reitzes noted that even though shares have gained nearly 25% year-to-date, he has “increased conviction” that investors will gain more confidence in AMD’s GPU prospects throughout the year. As such, AMD could be in the middle “of a historic run in the stock,” he added.
More on Advanced Micro Devices
- AMD: What To Do After A Quick 30% Rally
- AMD: Not Second Best To Nvidia, But It’s The Smarter Bet
- AMD: Forget Nvidia’s Shadow, $200 May Be Around The Corner
- Gainers & Losers in tech sector this week: Jabil gains while Enphase Energy declines
- Keysight rises as it says it aided AMD in testing server CPUs